Methylphenidate for freezing of gait in Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Lancet Neurology

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1474-4422(12)70145-XPMID 22710750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.

  2012cited by this paper
• Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.

  2011cited by this paper
• Freezing of gait: moving forward on a mysterious clinical phenomenon.

  2011cited by this paper
• Methylphenidate for gait impairment in Parkinson disease

  2011cited by this paper
• Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease.

  2010cited by this paper
• Atomoxetine for freezing of gait in Parkinson disease.

  2009cited by this paper
• Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype.

  2008cited by this paper
• The pathogenesis of gait hypokinesia in Parkinson's disease.

  1994cited by this paper
• Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes

  1993cited by this paper
• The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.

  1988cited by this paper

• Die Patientensicht auf Ganginitiierungsstörungen bei Morbus Parkinson - Validierung eines neuen Fragebogens zu Freezing of Gait (Gangfreezing) in deutscher Sprache

  2018cites this paper
• Neural correlates of gait disorders in neurological conditions

  2016cites this paper
• INFLUENCE OF PLANNING RESOURCES ON GAIT CONTROL IN PARKINSON’S DISEASE

  2015influential citation
• Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics.

  2015cites this paper
• What are the priorities in Parkinson's disease clinical research? A focus on motor complications, gait and cognition.

  2014cites this paper
• Motor planning in Parkinson's disease patients experiencing freezing of gait: the influence of cognitive load when approaching obstacles.

  2014cites this paper
• Implicit sequence learning in people with Parkinson’s disease

  2014cites this paper